Contract Biopharma, Jan. 24

Contract Research (CROs)

• ImmPACT Bio Raises $111 million in Series B Funding (USA)

• Evotec, Lily Strike Drug Discovery Partnership for Metabolic Diseases (Germany)

Contract Development and Manufacturing (CDMO)

• Forge Biologics Makes Plans to Expand Ohio Facility, to Increase Production Capabilities (USA)

• Catalent Increases Capabilities with Launch of Xpress Pharmaceuticals Service (USA)

• Procaps Invests in New Softgels Facility, to Increase Global Market Reach (USA)

• Selexis, Inotrem Collaborate on Antibody Cell Line Development (Switzerland)

• CBM, Penn Pave the Way for Smaller Biotechs as they Partner on Gene Therapy Development (USA)

• Vetter Manufacturing Facility Authorized for Operations (Austria)

Biopharma

• Entigix, Dompé Farmaceutici Enter AI-Driven Drug Discovery Collaboration (Italy)

• Hikamah Extends Global Presence into Canada in Acquisition of Teligent Assets (Canada)

• Xcellbio to Advance Production of New Cell Manufacturing Platform with $27.5M Series B Funding (USA)

• Abbisko, Lily Partner on Novel Molecule Discovery for Cardiometabolic Diseases (China)

• Aria Improves Pipeline with AI-Driven Computational Approach (USA)

Artificial Intelligence

• Valo, Charles River Partner to Use AI-enabled Platform in Discovery of Novel Molecules (USA)

• Sema4 Moves to Strengthen US Market Presence in Acquisition of GeneDx (USA)